... MTB infection was defined as including lung or mediastinal lymph node involvement. We de-fined multiorgan (ie, miliary) MTB infection as involve-ment of 2 or more organs (lymph nodes draining in- fected ... positive tubercu-lin skin test (TST) result in the absence of symptoms orclinical findings suggestive of active infection. In ana-lyzing LTBI treatment, we included studies reporting 10or more ... Tuberculosis Infectionin Liver Transplant Recipients 1. Approximately 1% of liver transplantrecipients develop active MTB infection. 2. Less than one-third of all liver transplant recipients...
... Medicine > Chapter 126. Infections inTransplant Recipients Infections inTransplant Recipients: Introduction The evaluation of infections intransplantrecipients involves consideration of ... corneal transplants. eT. gondii usually causes disease in the brain. In hematopoietic stem cell Chapter 126. Infections in Transplant Recipients (Part 1) Harrison's Internal Medicine ... recipient of the transplanted organ. Infections following transplantation are complicated by the use of drugs that are necessary to enhance the likelihood of survival of the transplanted organ...
... 126. Infections in Transplant Recipients (Part 2) In many transplantation centers, transmission of infections that may be latent or clinically inapparent in the donor organ has resulted in ... latent infections already. Nevertheless, most infections occur in a predictable time frame after transplantation (Table 126-2). Table 126-2 Common Sources of Infections after Hematopoietic ... bacteria Nocardia Candida, Aspergillus Encapsulated bacteria (Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis) Skin and mucous membranes HSV HHV-6 VZV Lungs...
... ulcerations occur in both the lower and the upper gastrointestinal tract, and it may be difficult to distinguish diarrhea due to GVHD from that due to CMV infection. The finding of CMV in the liver ... becomes available. Promising new drugs that are now being assessed in clinical trials include maribavir, a benzimidazole ribonucleoside that inhibits a viral protein kinase activity (UL97). ... abnormalities. It is interesting that the ocular and neurologic manifestations of CMV infections are uncommon in these patients. Management of CMV disease in HSCT recipients includes strategies...
... disease. Treatment of CMV pneumonia in HSCT recipients (unlike that in other clinical settings) involves both IV immune globulin (IVIg) and ganciclovir. In patients who cannot tolerate ganciclovir, ... Chapter 126. Infections in Transplant Recipients (Part 5) Like prophylaxis, preemptive treatment, which targets patients with polymerase chain reaction (PCR) evidence of ... antibodies to T cells). Although less likely in autologous transplantation, reactivation can occur in T cell–depleted autologous recipients (e.g., patients being given antibodies to T cells for the...
... critical in an assessment of posttransplantation infections. to have activity against the different forms of latent EBV infection. Preventing lytic replication in these patients would theoretically ... the Chapter 126. Infections in Transplant Recipients (Part 6) PCR can be used to monitor EBV production after hematopoietic stem cell transplantation. High or increasing viral loads predict ... resulted in disease in HSCT recipients, although some cases of virus-associated marrow aplasia have been reported in the peritransplantation period. The relatively low seroprevalence of KSHV in the...
... therapy (when indicated), and rapid diagnosis and treatment of infections can be lifesaving in SOT recipients, who, unlike most HSCT recipients, continue to be immunosuppressed. SOT recipients ... (Chap. 177). Intranasal pleconaril, a capsid-binding agent, is being studied for the treatment of enterovirus infection. Rhinoviruses and coronaviruses are frequent co-pathogens in HSCT recipients; ... acute infections inrecipients of SOT are different from those that infect HSCT recipients because SOT recipients do not go through a period of neutropenia. As the transplantation procedure involves...
... 126. Infections in Transplant Recipients (Part 8) Kidney Transplantation (See Table 126-4) Table 126-4 Common Infections after Kidney Transplantation Period after Transplantation Infection ... Prophylaxis of Infections inTransplantRecipients Risk Factor Organism Prophylactic Antibiotics Examination(s)a Travel to or residence in area with known risk of fungal infection ... chest imaging and/or no previous treatment Chest imaging; PPD and/or cell-based assay aSerologic examination, PPD testing, and interferon assays may be less reliable after transplantation....
... Chapter 126. Infections in Transplant Recipients (Part 9) Middle-Period Infections Because of continuing immunosuppression, kidney transplantrecipients are predisposed to lung infections ... Large ulcerating lesions in the anogenital area may lead to bladder and rectal dysfunction as well as predisposing to bacterial infection. VZV may cause fatal disseminated infection in nonimmune ... Legionella pneumophila infection (Chap. 141) led to the closing of renal transplant units in hospitals with endemic legionellosis. About 50% of all renal transplantrecipients presenting with fever...
... 126. Infections in Transplant Recipients (Part 10) Kidney transplantrecipients are also subject to infections with other intracellular organisms. These patients may develop pulmonary infections ... cause pulmonary infiltrates or disseminated disease. Late Infections Late infections (>6 months after kidney transplantation) may involve the CNS and include CMV retinitis as well as ... hominis infection is suspected. M. hominis mediastinitis has been cured with a combination of surgical debridement (sometimes requiring muscle-flap placement) and the administration of clindamycin...
... of lungtransplantrecipients with symptomatic CMV disease have pneumonia. Difficulty in distinguishing the radiographic picture of CMV infection from other Chapter 126. Infections in Transplant ... against CMV and is also active against HSV. The prophylaxis of CMV infection with IV ganciclovir—or increasingly with valganciclovir, the oral alternative—is recommended for lungtransplant recipients. ... Cryptococcus. Mediastinitis may occur at an even higher rate among lungtransplant recipients than among heart transplantrecipients and most commonly develops within 2 weeks of surgery. In the absence...
... these findings may suggest graft rejection, rejection is typically accompanied by marked elevation of Chapter 126. Infections in Transplant Recipients (Part 12) Late Infections The incidence ... Pneumocystis infection (which may present with a paucity of findings) is high among lung and heart -lung transplant recipients. Some form of prophylaxis for Pneumocystis pneumonia is indicated in all ... but also in the spleen, pericolic area, and pelvis. Treatment includes antibiotic administration and drainage as necessary. Liver transplant patients have a high incidence of fungal infections,...
... CMV infection, EBV-LPD, and infections with opportunistic pathogens in patients receiving a pancreatic transplant are similar to those in other SOT recipients. Miscellaneous Infections in Solid ... and yeast infections. Most pancreatic transplants are drained into the bowel, whereas the remaining transplants (~20%) are drained into the bladder. A cuff of duodenum is used in the anastomosis ... Organ Transplantation Indwelling IV Catheter Infections The prolonged use of indwelling IV catheters for administration of medications, blood products, and nutrition is common in diverse transplantation...
... P et al: Mycobacterium tuberculosis infectioninrecipients of solid organ transplants. Clin Infect Dis 40:581, 2005 [PMID: 15712081] Zerr DM et al: Clinical outcomes of human herpesvirus ... vaccines (Chaps. 116 and 117). In general, these patients should receive any killed or inactivated vaccine preparation appropriate to the area they are visiting; Chapter 126. Infections in ... Infections in Transplant Recipients (Part 14) In the absence of compelling data as to optimal timing, it is reasonable to administer the pneumococcal and H. influenzae type b conjugate vaccines to...
... vulvar carcinomas, quite clearly associated with HPV, develop with increased frequency in female transplant contacts contacts Poliomyelitis Administer inactivated vaccine Administer inactivated ... Chapter 126. Infections in Transplant Recipients (Part 15) Virus-Associated Malignancies In addition to malignancy associated with gammaherpesvirus infection (EBV, KSHV) and ... Cell Transplant (HSCT) or Solid Organ Transplant (SOT) Recipients Type of Transplantation Vaccine HSCT SOTa Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis...